Search Results 7621-7630 of 34098 for oral

1. A Study Of The Effect Of IW-1973 On The Exercise Capacity Of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) - Mayo Clinic

   The study will evaluate the effect of oral IW-1973 on peak exercise capacity in patients with HFpEF, with or without permanent or persistent atrial fibrillation ...

2. Parotid tumors - Doctors and departments - Mayo Clinic

   vascular surgery, Parotidectomy, Transoral laser microsurgery, Throat cancer, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck cancer ...

3. A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) - Mayo Clinic

   * Are receiving oral or injectable immunomodulating treatment for any other autoimmune disease prior to enrollment in the study. Patients who have been ...

4. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

   * Participant has demonstrated intolerance or inadequate response to one or more of the following categories of drugs: aminosalicylates, oral locally acting ...

5. Flaxseed: Is ground better than whole? - Mayo Clinic

   Flaxseed shouldn't be taken at the same time as oral medications. As always, talk with your doctor before trying any dietary supplements. There is a problem ...

6. S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer - Mayo Clinic

   Gastrointestinal (GI) disease or GI procedure that could interfere with the GI absorption or tolerance of TAK-700, including difficulty swallowing oral ...

7. Otolaryngology (ENT)/Head and Neck Surgery - Doctors - Mayo Clinic

   ... Oral surgery, Salivary gland surgery, Throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer ...

8. A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) - Mayo Clinic

   For participants taking oral corticosteroids (OCS), the dose has not been stable for at least 2 weeks prior to Visit 1 and/or is >10 milligram (mg) daily, or > ...

9. Publications - Allan M. Klompas, M.B., B.Ch., BAO - Mayo Clinic

   Contemporary Perioperative Management of Direct Oral Anticoagulants. Adv Anesth. 2022 Dec; 40(1):93-109. View PubMed; Liu VC, Klompas AM, Stulak JM, Yalamuri ...

10. Science Saturday: A new era in migraine care - Mayo Clinic News Network

    “This has been a life-changing experience for some of my patients, who have been able to stop taking some of their oral medications,” Dr. Starling says ...